30 results
8-K
LIANY
LianBio
20 Dec 23
LianBio Announces Departure of Chief Financial Officer
8:05am
infrastructure for the listing company. She was Sr. Finance Director at BeiGene from 2017 to 2019 and served as a member of BeiGene China Leadership … to 2017. She was a founding member of the Celgene China Leadership Team. Ms. Gu earned an MBA degree in Finance from the Rotman School of Management
8-K
EX-99.1
LIANY
LianBio
19 Dec 23
LianBio Announces Departure of Chief Executive Officer
4:26pm
Yizhe’s leadership, LianBio built a comprehensive cross-border platform for drug development, advanced multiple programs into pivotal Phase 3 trials
8-K
EX-99.1
LIANY
LianBio
1 May 23
Regulation FD Disclosure
7:28am
for oHCM by maximizing mavacamten’s value as the only treatment targeting the underlying pathophysiology of disease Market Leadership Improve diagnosis
8-K
EX-99.1
LIANY
LianBio
10 Nov 22
LianBio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
treatment guidelines, disease awareness campaign launch, and key commercial leadership hired
Pivotal Phase 3 LIBRA trial of TP-03 for the treatment … and Cardiomyopathy.
LianBio has hired key leadership roles to support the expected mavacamten commercial launch in China, including medical affairs personnel
8-K
EX-99.2
dicyaa88 58rm1
10 Nov 22
LianBio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.2
q2w z7ixfdtlbse
11 Aug 22
LianBio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-99.2
l8cg69lqryl
12 May 22
LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update
9:15am
DEFR14A
dc9b3cq
28 Apr 22
Revised proxy
5:10pm
DEF 14A
dhdv p4a0rbtr
27 Apr 22
Definitive proxy
8:17am
10-K
qz8tg0
31 Mar 22
Annual report
8:55am
8-K
EX-99.1
s87qmb 46pxwq6ixk
30 Mar 22
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:55pm
8-K
EX-99.1
0wta1r9q
2 Mar 22
Regulation FD Disclosure
4:42pm
10-Q/A
vbz1 8njp45bpwbx2t
10 Jan 22
Quarterly report (amended)
4:06pm
10-Q
ls61vxyh
9 Dec 21
Quarterly report
5:24pm
8-K
EX-99.1
h20co91
9 Dec 21
LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:59pm
424B4
fwlel idcug
2 Nov 21
Prospectus supplement with pricing info
4:02pm